JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by French Innovative Leukemia Organisation
Sponsor:
Information provided by (Responsible Party):
French Innovative Leukemia Organisation
ClinicalTrials.gov Identifier:
NCT01795677
First received: December 21, 2012
Last updated: March 15, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)